| 注册
首页|期刊导航|国医论坛|补火汤佐治慢性心力衰竭心肾阳虚证疗效观察

补火汤佐治慢性心力衰竭心肾阳虚证疗效观察

王芳

国医论坛2026,Vol.41Issue(2):26-30,5.
国医论坛2026,Vol.41Issue(2):26-30,5.

补火汤佐治慢性心力衰竭心肾阳虚证疗效观察

Observation on the Efficacy of Buhuo Decoction in Treating Chronic Heart Failure with Heart-kidney Yang Deficiency Syndrome

王芳1

作者信息

  • 1. 南阳市中心医院,河南南阳 473000
  • 折叠

摘要

Abstract

Objective To observe the clinical efficacy of Buhuo Decoction in patients with chronic heart failure(CHF)of heart-kidney yang deficiency syndrome(HKYDS).Methods A total of 98 patients with CHF of heart-kidney yang deficiency syndrome admitted to Nanyang Central Hospital from December 2022 to April 2025 were selected as the study subjects and divided into a control group and an observation group,with 49 cases in each group,using the envelope method.The control group was treated with conventional western medicine oral-ly,including captopril,spironolactone,metoprolol,and dapagliflozin.The observation group received additional treatment with Buhuo Decoction on this basis.After 3 months of treatment,the two groups were compared regard-ing symptom scores(primary symptoms,secondary symptoms,and total scores),clinical efficacy,levels of in-flammatory markers[soluble CD40 ligand(sCD40L),interleukin-1 β(IL-1β),and interleukin-6(IL-6)],cardiac markers[left ventricular ejection fraction(LVEF)and cardiac index(CI)],and the occur-rence of adverse reactions(palpitations,dizziness,gastrointestinal injury,abnormal liver and kidney function,etc).Results After treatment,the TCM symptom scores in the observation group were lower than those in the control group(P<0.05);the overall clinical efficacy rate in the observation group was 93.88%(46/49),which was superior to that in the control group[79.59%(39/49)](P<0.05);the levels of sCD40L,IL-1 β,and IL-6 in the observation group were lower than those in the control group(P<0.05);the LVEF and CI in the observation group were higher than those in the control group(P<0.05);the overall incidence of ad-verse reactions in the observation group was 8.16%(4/49),compared to 4.08%(2/49)in the control group,with no statistically significant difference between the groups(P>0.05).Conclusion Buhuo Decoction as an adjunctive therapy for CHF of heart-kidney yang deficiency syndrome can improve clinical symptoms and cardi-ac function,reduce levels of inflammatory factors,and enhance clinical efficacy,with good safety.

关键词

慢性心力衰竭/心肾阳虚证/补火汤/中西医结合疗法

Key words

Chronic Heart failure/Heart-kidney yang deficiency syndrome/Buhuo Decoction/Integrated tra-ditional Chinese and Western medicine therapy

分类

医药卫生

引用本文复制引用

王芳..补火汤佐治慢性心力衰竭心肾阳虚证疗效观察[J].国医论坛,2026,41(2):26-30,5.

国医论坛

1002-1078

访问量2
|
下载量0
段落导航相关论文